The identification of cancer biomarkers is critical for target‐linked cancer therapy. The overall
level of phosphatidylcholine ( PC ) is elevated in colorectal cancer ( CRC ). To investigate …

Shigella flexneri has evolved the ability to modify host cell function with intracellular active
effectors to overcome the intestinal barrier. The detection of these microbial effectors and the …

PURPOSE The International Union Against Cancer highlighted tumor budding as a tumor-related
prognostic factor. International assessment criteria for tumor budding were recently …

The clinicopathological characteristics relevant to prognosis after surgical treatment of
intrahepatic cholangiocarcinoma (ICC) remain unclear. In this study, the clinicopathological …

Background Efficacy of adjuvant chemotherapy in patients with stage II colon cancer is still
controversial. The SACURA trial is a randomised-controlled study evaluating the superiority of …

Background. Hepatic recurrence is seen in approximately 40% of patients undergoing
hepatectomy for colorectal metastases. This study was designed to assess the risks and clinical …

This retrospective study was designed to appraise the surgical procedures for pT2 gallbladder
(GB) carcinomas. Twenty patients with pT2 GB carcinomas underwent surgical resection. …

R-spondin (RSPO) gene fusions have recently been discovered in a subset of human
colorectal cancer (CRC) in the US population; however, whether the fusion is recurrent in CRC …

Small bowel obstruction ( SBO ) often occurs after total proctocolectomy and ileal pouch anal
anastomosis with diverting loop‐ileostomy for ulcerative colitis. Little is known about the …

Background Colitis-associated cancer (CAC) is one of the prognostic factors in inflammatory
bowel disease (IBD), and prevention of CAC is a critical concern for patients with IBD. …